使用131I标记马氏钳蝎氯毒素进行胶质瘤SPECT显像与放射性核素治疗
研究将131I标记于马氏钳蝎氯毒素(131I-BmK CT),评估其作为胶质瘤靶向显像与治疗工具的潜力。体外实验显示标记物放射化学纯度与稳定性满意,可剂量和时间依赖性抑制胶质瘤细胞生长并在细胞内显著蓄积。C6胶质瘤小鼠模型中瘤内注射与静脉注射均可显著抑制肿瘤并延长荷瘤小鼠生存,SPECT显像可清晰显示肿瘤。
要点
- 131I可成功标记BmK CT,放射化学纯度与稳定性满意。
- 131I-BmK CT以剂量和时间依赖性方式抑制胶质瘤细胞生长。
- 瘤内及静脉注射131I-BmK CT均可抑制C6胶质瘤并延长荷瘤小鼠生存。
核心结论
- 作者认为131I-BmK CT有潜力作为胶质瘤SPECT显像与放射性核素治疗的新型工具。
研究设计与样本
- 研究为体外细胞实验与C6胶质瘤荷瘤小鼠模型的实验研究。
主要发现
- 131I可成功与BmK CT连接,放射化学纯度与稳定性满意。
- 131I-BmK CT以剂量和时间依赖性方式明显抑制胶质瘤细胞生长,并在体外胶质瘤细胞中显著蓄积。
- C6胶质瘤肿瘤中观察到持续的瘤内放射性碘滞留和131I-BmK CT的特异性蓄积,SPECT显像可清晰显示。
- 瘤内注射和静脉注射131I-BmK CT均可产生显著的肿瘤抑制效果并延长荷瘤小鼠的生存时间。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gliomas, the most prevalent type of brain tumor in adults, are associated with high rates of morbidity and mortality. Recent studies on 131I labeled scorpion toxins suggest they can be developed as tumor-specific agents for glioma diagnosis and treatment. This study investigated the potential of 131I labeled Buthus martensii Karsch chlorotoxin (131I-BmK CT) as a new approach for targeted imaging and therapy of glioma. The results showed that 131I can be successfully linked to BmK CT with satisfactory radiochemical purity and stability and that 131I-BmK CT markedly inhibited glioma cell growth in a dose and time dependent manner, with significant accumulation in glioma cells in vitro. Persistent intratumoral radioiodine retention and specific accumulation of 131I-BmK CT were observed in C6 glioma tumor, which was clearly visualized by SPECT imaging. Both intratumoral and intravenous injections of 131I-BmK CT could result in significant tumor inhibition efficacy and prolonging the lifetime of tumor-bearing mice. Based on these promising results, it is concluded that 131I-BmK CT has the potential to be explored as a novel tool for SPECT imaging and radionuclide therapy of glioma.
引用
- Qiao W, Zhao L, Wu S, et al. SPECT imaging and radionuclide therapy of glioma using 131I labeled Buthus martensii Karsch chlorotoxin. J Neurooncol. 2017. PMID: 28488065. doi:10.1007/s11060-017-2456-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。